Clin2
NCT07697352Possibly a fitNot yet recruiting

Comparing two enzyme treatments for chronic pancreatitis

Pancreatitis, ChronicExocrine Pancreatic Insufficiency (EPI)

Part of Digestive system clinical trials.

This trial tests whether enzymes from microbes work as well as enzymes from pigs to help people with chronic pancreatitis digest food better. It aims to find a treatment that reduces symptoms like pain and poor digestion.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
134 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You have chronic pancreatitis, confirmed by a doctor.
  • Your pancreas does not make enough digestive enzymes, shown by a stool test.
  • You are willing to stop taking pancreatic enzymes for 2 weeks before starting the study.
  • You can give written consent to participate.
  • You do not have a severe mental illness or other condition that could affect the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07559175Recruiting· Phase 2
A new enzyme treatment for pancreatic insufficiency

This study tests a new pancreatic enzyme medicine (called NHS7108) for people with exocrine pancreatic insufficiency (EPI). EPI means your pancreas doesn't make enough enzymes to break down food properly. The study aims to see if this new medicine is safe and works well to help your body absorb nutrients.

Scottsdale, Arizona
NCT07450547Recruiting· Phase 2
A trial of a new medicine for cystic fibrosis and pancreatic problems

This trial tests a new medicine (ANG003) for people with cystic fibrosis who have severe pancreatic problems. It looks at how safe and effective the medicine is, and whether it helps with digestion.

Long Beach, California
NCT06729996Recruiting· Phase 2
Comparing two diabetes medicines for pancreatitis-related diabetes

This trial tests whether pioglitazone or empagliflozin is better at managing diabetes caused by chronic or recurrent pancreatitis. You will take one of these pills daily for 6 months and track your blood sugar and ketones at home. The goal is to find a safer, more effective treatment for this type of diabetes.

Rochester, Minnesota
NCT06477159Recruiting· Phase 4
Enzyme replacement for acute pancreatitis recovery

This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.

Los Angeles, California
NCT07751367Not yet recruiting
Digestive enzyme pills for pancreatic insufficiency after gastrointestinal surgery

This trial tests two different doses of a digestive enzyme pill to see which works better for people who have trouble digesting food after stomach or pancreatic surgery. The goal is to improve digestion and quality of life.

Tianjin, Tianjin Municipality
NCT07418593Recruiting· Phase 4
Blood test for pancreas function in chronic pancreatitis

This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.

Baltimore, Maryland

Hear when a new Pancreatitis, Chronic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.